Je kunt je niet meer inschrijven voor dit webinar
Watch this webinar on 28 September 16.00 hrs. (CET) and learn about:
  • Development, optimization and miniaturization of screening assay cascade
  • ultra-Hgh-Throughput Screening of large compounds
  • Hit validation and triaging
​​​​​​​The innate immune system is crucial for initiation and amplification of inflammatory responses and tissue destruction in many diseases. Calcium binding proteins plays a major role in Immune-Mediated Inflammatory Diseases, some of which are currently used as diagnostic biomarkers in a subset of inflammatory diseases. Several pro-inflammatory functions have been ascribed to calcium binding proteins and as such, making them solid targets for small-molecule therapeutics.
Presentation by:
Dr. Saman Honarnejad - Director Drug Discovery, Pivot Park Screening Centre

Duration
Presentation: 45 minutes (16:00 hrs. CET)
You can view this webinar from your computer, tablet or mobile phone.

​About the presenter:
Dr. Saman Honarnejad is a biotechnologist with over a decade of experience in High Throughput Biology. At Pivot Park Screening Centre (PPSC) in Oss, the Netherlands, he is involved in cellular and biochemical assay development, ultra-High Throughput screening (uHTS) and Hit-to-Lead (H2L) biological compound profiling within a wide range of commercial, academic and public-private partnership projects including the European Lead Factory (ELF).

Prior to joining PPSC in 2017, he was active in high-content compound profiling method development at Max-Planck Institute (Germany), Harvard Medical School (United States) and Heidelberg University (Germany) and further optimized microarray-based cDNA/RNAi functional screening assays at the European Molecular Biology Laboratory (EMBL). 

https://www.ppscreeningcentre.com/

Share this webinar